TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02401711

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education - BIPS course
Description: The guiding principles behind the BIPS program include: (1) explaining how complex systems cause human error and how human error can lead to patient harm in complex systems; (2) diagnosing human error and identifying a prevention behavior for each of the three types: skill, rule, and knowledge; and (3) preventing error by promoting safety behaviors, such as having attention to detail, communicating clearly, having a questioning attitude, and speaking up for safety

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education - BIPS course
Description: The guiding principles behind the BIPS program include: (1) explaining how complex systems cause human error and how human error can lead to patient harm in complex systems; (2) diagnosing human error and identifying a prevention behavior for each of the three types: skill, rule, and knowledge; and (3) preventing error by promoting safety behaviors, such as having attention to detail, communicating clearly, having a questioning attitude, and speaking up for safety

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Formal safety curriculum
Description: The educational program is designed to improve patient safety by informing residents about safe operating room behaviors.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ongoing evaluation and feedback
Description: The feedback program is designed to encourage the use of safe behaviors and to discourage unsafe behaviors taught in the workshops.
Study: NCT00967785

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mozobil (TM)
Description: twice daily subcutaneous injection or via continuous subcutaneous infusion
Study: NCT02362217

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA.HIVconsv
Description: Genetic vaccine against HIV-1 infection
Study: NCT02529345

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RoadSaver stent
Description: lesion treated with RoadSaver stent of Terumo
Study: NCT03330730

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IsereADOM service package
Description: Objects connected to patients' homes (thermometer, weight scale, tensiometer +/- oximeter, glucose meter or pedometer), Digital liaison booklet, Sentinel referent, Motivational coaching
Study: NCT03631472

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RheOx
Description: RheOx is a device-based, energy delivery system that delivers energy to ablate soft tissue such as the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.
Study: NCT01354977

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Resveratrol
Description: 1,000mg twice daily for 28 days
Study: NCT03178877

Intervention type: OTHER
Intervention: No intervention

Intervention type: OTHER
Intervention: No intervention
Study: NCT03527433

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: New closure technique
Description: In the intervention arm, an average of two sutures will be placed at each cm length of the wound, thus the number of sutures placed should be equal to at least double the length of the wound in cm.The aim is to have a ratio of 4:1 between the overall lengths of the suture to the length of the wound being closed
Study: NCT01262638

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ETC-1002
Description: ETC-1002 daily for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo daily for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo daily for 12 weeks
Study: NCT03938532

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Volume Targeted Ventilation (VTV) using the Philips Respironics NM3 monitor
Description: Infants in the intervention arm will receive VTV following intubation. Peak inspiratory pressure (PiP) provided via T-piece resuscitator will be visible to the providers, and the provider can regulate the PiP to achieve the desired TV goal (4-6 ml/kg), at a rate of 40-60 breaths/min

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tidal Volume Measurement using the Philips Respironics NM3 monitor
Description: Tidal Volume Measurement using the Philips Respironics NM3 monitor
Study: NCT02331914

Intervention type: PROCEDURE
Intervention: Vena puncture for blood collection
Description: GIST patients will be asked to provide 40ml blood that will be collected in four Na-EDTA 10ml blood collection tubes at every routine outpatient visit.

Intervention type: PROCEDURE
Intervention: Tumor biopsy
Description: Tumor biopsy after disease progression
Study: NCT04833686

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mozart
Description: Music composed by Mozart, a musical piece 24 minutes long.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Instrumental music
Description: Instrumental music , a musical piece 24 minutes long

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Silence
Description: Silence, a piece 24 minutes long.
Study: NCT01536093

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: oropharyngeal administration of own mother's colostrum
Description: application of 0.2 mL of colostrum to the infant's oropharyngeal mucosa every 3 hours for 3 days from the postnatal 48 to 96 hours.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: oropharyngeal administration of sterile water
Description: application of 0.2 mL of sterile water to the infant's oropharyngeal mucosa every 3 hours for 3 days from the postnatal 48 to 96 hours.
Study: NCT03643341

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Healthy Living
Description: Children aged 8-12 and at least one caregiver will meet for 10 weekly intervention sessions (1.5 hours per session), and 4 extra sessions to be chosen by families and intervention Leaders. During the intervention, participants will also have access to digital educational content that is supplementary to what is provided during the individual sessions. Four biweekly maintenance sessions will follow the main program.
Study: NCT04033315

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: L-PLUS meter
Description: Blood Glucose Monitoring System
Study: NCT00909324

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pre-LASIK 0.3% hypromellose
Description: Patients self-administered GenTeal eye drops qid (quarter in die, 4 times a day) starting 5 days prior to LASIK surgery and continuing through 1 month after LASIK surgery.
Study: NCT01036581

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MagPro X100 Magnetic Stimulator
Description: Concurrent TMS-MRI acquisition allows us to investigate the acute effects of induced brain activity on BOLD signal and evaluate interference of the TMS pulse with the BOLD signal measurement.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MagPro X100 Magnetic Stimulator
Description: Concurrent TMS-MRI acquisition allows us to investigate the acute effects of induced brain activity on BOLD signal and evaluate interference of the TMS pulse with the BOLD signal measurement.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Rotating Magnetic Stimulator
Description: Participants will undergo transcranial rapid rotating permanent magnetic stimulation (TRPMS), with the aim of evaluating the prolonged effect of TRPMS on motor cortex excitability. In another experiment, participants will undergo TRPMS with the aim of evaluating cortical excitability changes with TRPMS. These experiments will help interpret subsequent experiments investigating the effect of TRPMS on BOLD signal.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Rotating Magnetic Stimulator
Description: Participants will undergo transcranial rapid rotating permanent magnetic stimulation (TRPMS), with the aim of evaluating the prolonged effect of TRPMS on motor cortex excitability. In another experiment, participants will undergo TRPMS with the aim of evaluating cortical excitability changes with TRPMS. These experiments will help interpret subsequent experiments investigating the effect of TRPMS on BOLD signal.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Rotating Magnetic Stimulator
Description: Participants will undergo transcranial rapid rotating permanent magnetic stimulation (TRPMS), with the aim of evaluating the prolonged effect of TRPMS on motor cortex excitability. In another experiment, participants will undergo TRPMS with the aim of evaluating cortical excitability changes with TRPMS. These experiments will help interpret subsequent experiments investigating the effect of TRPMS on BOLD signal.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetom Prisma Fit 3T Scanner
Description: Type: MRI Name: Magnetom Prisma Fit 3T Scanner (Siemens) Description: Functional and structural magnetic resonance imaging techniques are used for noninvasive mapping of brain physiology and pathology and to develop advanced magnetic resonance imaging and spectroscopy (MRI and MRS) techniques for neuroimaging studies related to addiction.
Study: NCT01362803

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD6244
Description: AZD6244 orally (at recommended Ph2 dose) every 12 hours on continuous daily schedule for cycles of 28 days until unacceptable toxicity, patient withdrawal or PD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD6244
Description: AZD6244 orally (at recommended Ph2 dose) every 12 hours on continuous daily schedule for cycles of 28 days until unacceptable toxicity, patient withdrawal or PD
Study: NCT02858336

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NEA
Description: Neutral Energy Availability: 5-day outpatient intervention of prescribed diet and exercise to elicit an energy availability of 45 kcal/kg LBM day.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DEA
Description: Deficient Energy Availability: 5-day outpatient intervention of prescribed diet and exercise to elicit an energy availability of 20 kcal/kg LBM day.
Study: NCT03907826

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 blocking antibody
Description: Toripalimab 240mg, D1, every 3 weeks per cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GP
Description: Gemcitabine 1.0g/m2, D1 and D8; Cisplatin 80mg/m2, D1, every 3 weeks per cycle, total three cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GP
Description: Gemcitabine 1.0g/m2, D1 and D8; Cisplatin 80mg/m2, D1, every 3 weeks per cycle, total three cycles

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: IMRT
Description: IMRT 60-66Gy, 1.8-2.0Gy/f/day

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT
Description: IMRT 60-66Gy, 1.8-2.0Gy/f/day
Study: NCT04317677

Intervention type: OTHER
Group type: OTHER
Intervention: Study of the effect of bladder voiding on sleep fragmentation during day and night sleep
Description: Vigilance state of babies will be continuously recorded during the first 24 hours of hospitalization by polysomnography and actigraphy. In parallel, bladder voiding episodes will be detected with an innovative device placed on babies diapers.
Study: NCT00909324

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Post-LASIK 0.3% hypromellose
Description: Patients self-administered GenTeal eye drops qid (quarter in die, 4 times a day) starting on the day of LASIK surgery and continuing through 1 month after surgery.
Study: NCT03666468

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PlayMed
Description: A highly immersive role-playing computer game focused on Paediatric Asthma and Seizure management
Study: NCT01887561

Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: dasatinib
Study: NCT02305472

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeoVas BCS
Description: Subjects receiving NeoVas BCS
Study: NCT05073796

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cochlea Implant
Description: * examination and documentation of vital signs and concomitant medication~* application of an cochlea implant loan processor (external body surface) with varying stimulus pattern for vestibular stimulation by means of basal, medial and apical electrodes~* attraction of an special mask to determine the subjective visual vertical (SVV)~* assessment of the vertical spatial axis with all electrodes turned off~* assessment of the vertical spatial axis with all electrodes turned on~* assessment of the vertical spatial axis while using basal (12-16) and medial (6-11) electrodes~* assessment of the vertical spatial axis while using basal (12-16) and apical (1-5) electrodes~* assessment of the vertical spatial axis while using medial (6-11) and apical (1-5) electrodes
Study: NCT02450461

Intervention type: OTHER
Intervention: no intervention

Intervention type: OTHER
Intervention: no intervention
Study: NCT03895580

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: In-store POP education
Description: Six in-store nutrition counseling sessions with a registered dietitian nutritionist.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: In-store POP education
Description: Six in-store nutrition counseling sessions with a registered dietitian nutritionist.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online POP education
Description: Education on the use of an online grocery shopping, an online recipe tool, a grocery pickup service, a home grocery delivery service, and a phone application that promotes healthy food selection.
Study: NCT00778375

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofarabine
Description: 20 mg/m\^2 by vein as a 1- to 2-hour intravenous infusion daily for 5 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: 20 mg subcutaneously twice daily for 10 days, administered 3 to 6 hours following the start of the clofarabine infusions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: 20 mg/m\^2 as a 1- to 2-hour infusion daily for 5 days.
Study: NCT03220464

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ultra low dose chest computed tomography (ULDCT)
Description: Participants in the study will receive ULDCT at enrollment, after 3-month visit, and after 12-month visit.
Study: NCT01876160

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Study: NCT01648946

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Red blood cell transfusion
Description: Red blood cell (RBC) transfusion will be given when hemoglobin falls below 9 g/dL since ICU admission until the discharge of intensive care unit. Following administration of 1 RBC unit, a repetition of hemoglobin levels is performed; if a patient's hemoglobin level is 9 g/dL or higher, no additional transfusion is necessary.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Red blood cell transfusion
Description: Red blood cell (RBC) transfusion will be only given when hemoglobin falls below 7 g/dL since ICU admission until the discharge of intensive care unit. Following administration of 1 RBC unit, a repetition of the hematocrit is performed; if a patient's hemoglobin is 7 g/dL or higher, no additional transfusion is necessary.
Study: NCT01035515

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose oral capsule placebo comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose oral capsule placebo comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose oral capsule placebo comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose oral capsule placebo comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose oral capsule placebo comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose oral capsule placebo comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB014 50mg
Description: Single dose oral capsule 50mg BIIB014

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB014 50mg
Description: Single dose oral capsule 50mg BIIB014

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB014 50mg
Description: Single dose oral capsule 50mg BIIB014

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB014 50mg
Description: Single dose oral capsule 50mg BIIB014

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB014 50mg
Description: Single dose oral capsule 50mg BIIB014
Study: NCT01512589

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton Beam Therapy (PBT)
Description: 1.8 Gy (Relative Biologic Equivalence ((RBE)) to be delivered to the periphery of the planning target volume (PTV) 1 time each day, 5 days a week (Monday through Friday) for up to 28 treatments.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Description: 1.8 Gy to be delivered to the periphery of the planning target volume (PTV) 1 time each day, 5 days a week (Monday through Friday) for up to 28 treatments.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Symptom and Quality of Life questionnaires completed at baseline, every week during radiation therapy, during break after radiation therapy, and during follow up phase.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Symptom and Quality of Life questionnaires completed at baseline, every week during radiation therapy, during break after radiation therapy, and during follow up phase.
Study: NCT04214262

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fludeoxyglucose F-18
Description: Undergo FDG PET/CT

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fludeoxyglucose F-18
Description: Undergo FDG PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study: NCT03220464

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Chest X-ray
Description: Participants in the study will receive chest x-ray at enrollment, after 3-month visit, and after 12-month visit.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Interferon-gamma Release Assay (IGRA)
Description: Participants in the study will receive IGRA test at enrollment, after 3-month visit, and after 12-month visit. About 11mL of blood will be drawn from the participants for test of T-SPOT®.TB test and QuantiFERON test.
Study: NCT03287934

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: selective laser sintered stent
Description: after planning and virtual implant placement, a guide will be designed and the STL file will be send to prototyping center for printing the guide with selective laser sintering technique. during the surgical procedure , the target tooth will be atraumatic extracted, the stent is adapted in its place then implant drilling and placement will be done.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: selective laser sintered stent
Description: after planning and virtual implant placement, a guide will be designed and the STL file will be send to prototyping center for printing the guide with selective laser sintering technique. during the surgical procedure , the target tooth will be atraumatic extracted, the stent is adapted in its place then implant drilling and placement will be done.
Study: NCT04214262

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET/CT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study: NCT03287934

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital light processing(dlp)
Description: after planning and virtual implant placement, a guide will be designed and the STL file will be send to prototyping center for printing the guide with digital light processing technique. during the surgical procedure , the target tooth will be atraumatic extracted, the stent is adapted in its place then implant drilling and placement will be done.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: digital light processing(dlp)
Description: after planning and virtual implant placement, a guide will be designed and the STL file will be send to prototyping center for printing the guide with digital light processing technique. during the surgical procedure , the target tooth will be atraumatic extracted, the stent is adapted in its place then implant drilling and placement will be done.
Study: NCT04103944

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Core Decompression
Description: 10 patients will be randomized chosen in this group

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteonecrotic Repair Device
Description: 10 patients will be randomized chosen in this group
Study: NCT04214262

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT02753907

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low LA
Description: Individuals who replaced 10 mL soy oil with one apple

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High LA
Description: Individuals who reduced 1/3 cup of cooked refined rice and consumed 9.9g (9 of 1.1g capsules, 3 capsules at every 3 meals a day) of soy oil as a supplement
Study: NCT04009694

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle training
Description: Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist
Study: NCT05608395

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 11C-Methionine PET/CT
Description: 11C-Methionine PET/CT will be applied in patients in 11C-Methionine PET/CT Arm, based on planning MRI, prior chemo/radiotherapy (2 weeks prior C1D1)